CURX
Price
$4.92
Change
-$0.06 (-1.20%)
Updated
Oct 2, 01:09 PM (EDT)
Capitalization
7.9M
Intraday BUY SELL Signals
ICU
Price
$4.75
Change
+$1.00 (+26.67%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
14.98M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CURX vs ICU

CURX vs ICU Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CURX vs. ICU commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURX is a StrongBuy and ICU is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
CURXICU
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (CURX: $4.98 vs. ICU: $3.75)
Brand notoriety: CURX and ICU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CURX: 58% vs. ICU: 40%
Market capitalization -- CURX: $7.9M vs. ICU: $14.98M
CURX [@Biotechnology] is valued at $7.9M. ICU’s [@Biotechnology] market capitalization is $14.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CURX’s FA Score shows that 1 FA rating(s) are green while ICU’s FA Score has 1 green FA rating(s).

  • CURX’s FA Score: 1 green, 4 red.
  • ICU’s FA Score: 1 green, 4 red.
According to our system of comparison, ICU is a better buy in the long-term than CURX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CURX’s TA Score shows that 3 TA indicator(s) are bullish while ICU’s TA Score has 5 bullish TA indicator(s).

  • CURX’s TA Score: 3 bullish, 5 bearish.
  • ICU’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ICU is a better buy in the short-term than CURX.

Price Growth

CURX (@Biotechnology) experienced а +15.55% price change this week, while ICU (@Biotechnology) price change was +9.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

ICU is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CURX
Daily Signal:
Gain/Loss:
ICU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JYD0.890.11
+13.59%
Jayud Global Logistics Limited
ATO156.38-0.06
-0.04%
Atmos Energy Corp
BWMN42.59-0.05
-0.12%
Bowman Consulting Group Ltd
BATRK52.25-0.69
-1.30%
Atlanta Braves Holdings
RYDE0.68-0.03
-4.06%
Ryde Group Ltd

CURX and

Correlation & Price change

A.I.dvisor tells us that CURX and ICU have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CURX and ICU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURX
1D Price
Change %
CURX100%
-1.34%
ICU - CURX
30%
Poorly correlated
-4.82%
CSBR - CURX
30%
Poorly correlated
-0.50%
NVAX - CURX
29%
Poorly correlated
-1.94%
ABCL - CURX
26%
Poorly correlated
-4.66%
VCEL - CURX
25%
Poorly correlated
-1.74%
More